Journal of Clinical Virology
Volume 47, Issue 1 , Pages 29-33 , January 2010

Optimization and evaluation of an influenza A (H5) pseudotyped lentiviral particle-based serological assay

  • Jean-Michel Garcia

      Affiliations

    • HKU-Pasteur Research Centre, Hong Kong, SAR China
    • Corresponding Author InformationCorresponding authors at: HKU-Pasteur Research Centre, Dexter H.C. Man Building, 8 Sassoon Road, Pokfulam, Hong Kong, SAR China. Tel.: +852 2816 8417; fax: +852 2872 5782.
    • ,
  • Nadège Lagarde

      Affiliations

    • HKU-Pasteur Research Centre, Hong Kong, SAR China
    • ,
  • Edward S.K. Ma

      Affiliations

    • University of Hong Kong, Hong Kong, SAR China
    • ,
  • Menno D. de Jong

      Affiliations

    • Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam
    • ,
  • J.S. Malik Peiris

      Affiliations

    • HKU-Pasteur Research Centre, Hong Kong, SAR China
    • University of Hong Kong, Hong Kong, SAR China
    • Corresponding Author InformationCorresponding authors at: HKU-Pasteur Research Centre, Dexter H.C. Man Building, 8 Sassoon Road, Pokfulam, Hong Kong, SAR China. Tel.: +852 2816 8417; fax: +852 2872 5782.

Received 3 June 2009 ,Revised 1 October 2009 ,Accepted 7 October 2009.

References 

  1. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD, et al. Writing committee of the second world health organization consultation on clinical aspects of human infection with avian influenza A (H5N1) virus. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med. 2001;358:261–273
  2. WHO. Manual on animal influenza diagnosis and surveillance, WHO/CDS/CSR/NCS/2002.5.
  3. Kayali G, Setterquist SF, Capuano AW, Myers KP, Gill JS, Gray GG. Testing human sera for antibodies against avian influenza viruses: horse RBC hemagglutination inhibition vs. microneutralisation assays. J Clin Virol. 2008;43:73–78
  4. Stephenson I, Wood JM, Nicholson KG, Charlett A, Zambon MC. Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. Virus Res. 2004;103:91–95
  5. Nicolson C, Major D, Wood JM, Robertson JS. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine. 2005;23:2943–2952
  6. Nefkens I, Garcia JM, Lagarde N, Chu K, Peiris JS, Buchy P, et al. Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis. J Clin Virol. 2007;39:27–33
  7. Temperton NJ, Hoschler K, Major D, Nicolson C, Manvell R, Hien VM, et al. A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respi Viruses. 2007;1:105–112
  8. Wang W, Butler EN, Veguilla V, Vassell R, Thomas JT, Moos M, et al. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J Virol Methods. 2008;153:111–119
  9. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12:1203–1207
  10. de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. 2005;353:2667–2672
  11. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med. 2004;350:1179–1188
  12. Choi YK, Nguyen TD, Ozaki H, Webby RJ, Puthavathana P, Buranathal C, et al. Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J Virol. 2005;79:10821–10825
  13. Hill AV. The possible effects of aggregation of the molecules of hemoglobin on its dissociation curves. J Physiol (Lond). 1910;40:4–7
  14. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;27:493–497
  15. Akoben AK. Understanding diagnostic tests 1: sensitivity, specificity and predictive values. Acta Paediatr. 2006;96:338–341
  16. Douglass CW. Evaluating diagnostic tests. Adv Dent Res. 1993;7:66–69
  17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–310
  18. Akoben AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007;96:644–647
  19. Perkins NJ, Schisterman EF. The inconsistency of ‘optimal’ cutpoints obtained using the two criteria based on the receiver operating characteristics curve. Am J Epidemiol. 2006;163:670–675
  20. Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biomed J. 2005;47:458–472
  21. Hanley JA, McNeil BJ. The meaning and use of the area under the receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36
  22. Caporal-Gautier J, Nivet JM, Algranti P, Guilloteau M, Histe M, Lallier M, et al. Guide de validation analytique. Rapport d’une commission SFSTP. I. Methodologie. STP Pharma Pratiques. 1992;2:205–226
  23. Katz JM, Lim W, Bridges CB, Rowe T, Hu-Primmer J, Lu X, et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis. 1999;180:1763–1770
  24. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med. 2006;354:1343–1351

PII: S1386-6532(09)00499-5

doi: 10.1016/j.jcv.2009.10.009

Journal of Clinical Virology
Volume 47, Issue 1 , Pages 29-33 , January 2010

Article Tools

* Image Usage & Resolution